Insights
29 April 2024
Software in Asia
Underpinned by continued digitalisation, rapid adoption of localised, cloud-native…
16 April 2024
China Healthcare M&A outlook for 2024
In China’s dynamic healthcare market, M&A activities are booming…
13 March 2024
HealthTech sector landscape
The HealthTech industry has seen substantial expansion in recent years,…
About us
We are a premium provider of Asia-related advice to sophisticated clients globally, with over 25 years’ experience and a strong track record for advising corporates and financial sponsors on cross-border M&A, capital raising, and financial restructuring.
As the leading sellside investment banking advisor for Asia, we specialize in cross-border transactions and have over 120 bankers throughout our nine offices located across North America, Europe and Asia.
At a glance
#1
Cross-border Asian sellside M&A advisor†
1996
Founded and led since then by the same senior team
80%
Of transactions are cross-border
120+
Bankers collaborating seamlessly across three continents
Recent transactions
acquired majority stake in
2024
divested Oriental Foods and IIT Corporation to
2024
divested majority stake in
to
2024
raised growth capital from a consortium led by
2024
divested majority stake in
to
2024
acquired majority stake in
2024
acquired 70% of
2023
a portfolio company of
has been acquired by
2023
divested Crefact to
2023
†Private companies headquartered in China, India, Japan, Korea or Southeast Asia; Control transactions up to US$1bn enterprise value, 2016-2022 Source: Dealogic